Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3
- 1 December 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 19 (12), 923-934
- https://doi.org/10.1097/fpc.0b013e3283330767
Abstract
Objectives Characterize the expression and glucuronidation activities of the human uridine 5′-diphospho (UDP)-glucuronosyltransferase (UGT) 2A2. Method UGT2A1 was cloned from nasal mucosa mRNA. Synthetic cDNA for UGT2A2 was constructed assuming exon sharing between UGT2A1 and UGT2A2 (Mackenzie et al., Pharmacogenetics and Genomics 2005, 15:677–685). Exon 1 of UGT2A2 was amplified from genomic DNA and combined with exons 2–6 of UGT2A1. UGT2A3 was cloned from liver mRNA. Quantitative reverse-transcribed-PCR (RT-PCR) was used to evaluate the expression of all the three UGTs of subfamily 2A in different tissues. Recombinant UGT2A1, UGT2A2 and UGT2A3 were expressed in baculovirus-infected insect cells and analyzed for glucuronidation activity towards different substrates. Results DNA sequencing of RT-PCR products from human nasal mucosa mRNA, confirmed exon sharing between UGT2A1 and UGT2A2. In addition, it indicated that the N-terminal signal peptide sequence of UGT2A2 is the longest among the human UGTs. Quantitative RT-PCR revealed that both UGT2A1 and UGT2A2 are mainly expressed in the nasal mucosa, and that their expression level in fetal samples was much higher than in adults. Activity assays with recombinant UGTs 2A1–2A3 showed broad substrate selectivity for UGT2A1 and UGT2A2. Although glucuronidation rates and substrate affinities were mostly higher in UGT2A1, the Km values for UDP-glucuronic acid were similar in both UGTs. In addition, there were regioselectivity differences between the two UGTs and, with a few substrates, particularly ethinylestradiol, the activity of UGT2A2 was higher. Conclusion UGT2A2 is mainly expressed in the nasal mucosa and it has glucuronidation activity towards several different endobiotic and xenobiotic substrates.Keywords
This publication has 37 references indexed in Scilit:
- Identification of UDP Glycosyltransferase 3A1 as a UDP N-AcetylglucosaminyltransferaseOnline Journal of Public Health Informatics, 2008
- Kinetic Modeling of the Interactions between 4-Methylumbelliferone, 1-Naphthol, and Zidovudine Glucuronidation by UDP-Glucuronosyltransferase 2B7 (UGT2B7) Provides Evidence for Multiple Substrate Binding and Effector SitesMolecular Pharmacology, 2008
- Novel Polymorphic Human UDP-glucuronosyltransferase 2A3: Cloning, Functional Characterization of Enzyme Variants, Comparative Tissue Expression, and Gene InductionMolecular Pharmacology, 2008
- Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell LinesDrug Metabolism and Disposition, 2008
- A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human HepatocytesDrug Metabolism and Disposition, 2007
- Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo ExtrapolationThe Journal of pharmacology and experimental therapeutics, 2007
- Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and NonsmokersEnvironmental Health Perspectives, 2006
- Human UDP-Glucuronosyltransferase 1A5: Identification, Expression, and ActivityThe Journal of pharmacology and experimental therapeutics, 2005
- EXPRESSION OF CYTOCHROME P450 AND OTHER BIOTRANSFORMATION GENES IN FETAL AND ADULT HUMAN NASAL MUCOSADrug Metabolism and Disposition, 2005
- GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASEDrug Metabolism and Disposition, 2004